computationally designed antigen targets range of coronaviruses
In a recent study published in Nature Biomedical Engineering, researchers used an interdisciplinary approach incorporating phylogenetics, 3D protein modeling, and ...
In a recent study published in Nature Biomedical Engineering, researchers used an interdisciplinary approach incorporating phylogenetics, 3D protein modeling, and ...
An adapted COVID-19 vaccine from Moderna (Spikevax) that targets the Omicron XBB 1.5 subvariant, has today been authorized by the ...
In a recent preprint posted to the bioRxiv* server, researchers characterized two novel XBB variants, EG.5.1 and XBB.2.3, with the former ...
New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them ...
The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or ...
In a recent article published in the Lancet Infectious Diseases, researchers performed a phase I randomized clinical trial between November 7, ...
In a recent study posted to the SSRN* preprint server, researchers presented a stochastic model of yellow fever transmission based ...
A recent study published in the BMJ investigated the associations between coronavirus disease 2019 (COVID-19) vaccination or non-vaccination and adverse ...
In a recent study posted in the bioRxiv* preprint server, researchers explored the impact of a loss-of-function mutation in the ...
In a recent study published in the Emerging Infectious Diseases Journal, researchers explored the possible transmission of severe acute respiratory ...
Forget walking 10,000 steps a day. Taking at least 50 steps climbing stairs each day could significantly slash your risk...
Read moreExamples of mismatched materials of varying thermal dynamics, cured at various temperatures, causing warpage, cracking and potential breakage. The results...
Read moreA new study shows that delivery of gene therapy to correct the gene mutations that cause CLN2 disease, or Batten...
Read moreAmbu CEO Britt Meelby Jensen Ambu’s CEO seeks to “Zoom In” on what the Danish company has done best. More...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.